Credit Suisse’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $1.87M | Buy |
|
|||||
|
2023
Q4 | $1.82M | Buy |
|
|||||
|
2023
Q3 | $1.26M | Sell |
|
|||||
|
2023
Q2 | $1.91M | Buy |
|
|||||
|
2023
Q1 | $1.42M | Buy |
|
|||||
|
2022
Q4 | $1.55M | Buy |
|
|||||
|
2022
Q3 | $1.04M | Buy |
|
|||||
|
2022
Q2 | $486K | Sell |
|
|||||
|
2022
Q1 | $598K | Sell |
|
|||||
|
2021
Q4 | $501K | Buy |
|
|||||
|
2021
Q3 | $376K | Buy |
|
|||||
|
2021
Q2 | $369K | Sell |
|
|||||
|
2021
Q1 | $399K | Sell |
|
|||||
|
2020
Q4 | $646K | Sell |
|
|||||
|
2020
Q3 | $910K | Buy |
|
|||||
|
2020
Q2 | $1.37M | Sell |
|
|||||
|
2020
Q1 | $1.23M | Sell |
|
|||||
|
2019
Q4 | $2.11M | Buy |
|
|||||
|
2019
Q3 | $300K | Buy |
|
|||||
|
2019
Q2 | $182K | Buy |
|
|||||
|
2019
Q1 | $110K | Buy |
|
|||||
|
2018
Q4 | $29K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $78K | Sell |
|
|||||
|
2018
Q1 | $75K | Buy |
|
|||||
|
2017
Q4 | $84K | Sell |
|
|||||
|
2017
Q3 | $120K | Buy |
|
|||||
|
2017
Q2 | $38K | Sell |
|
|||||
|
2017
Q1 | $31K | Buy |
|
|||||
|
2016
Q4 | $17K | Sell |
|
|||||
|
2016
Q3 | $157K | Sell |
|
|||||
|
2016
Q2 | $302K | Buy |
|
|||||
|
2016
Q1 | $115K | Buy |
|
|||||
|
2015
Q4 | $137K | Buy |
|
|||||
|
2015
Q3 | $104K | Sell |
|
|||||
|
2015
Q2 | $162K | Sell |
|
|||||
|
2015
Q1 | $693K | Buy |
|
|||||
|
2014
Q4 | $193K | Buy |
|
|||||
|
2014
Q3 | $151K | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $12K | Buy |
|